Form D · Other Health Care
AltraVax, Inc.
Rochester, MN · CIK 0001475602
Offering snapshot reported Nov 30, 2009 · SEC filing
- Reported sold
- $2M Offering amount: $7.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 18, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 30, 2009 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Oct 30, 2009 | Initial | $7,250 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-135710
Total Offering Amount and Total Remaining to be Sold include $1,500,000 receivable only upon exercise of Warrants.
Source: Form D, filed Nov 30, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald Bergan | Director |
| James Burgum | Director |
| Michael Chambers | Director, Promoter |
| Scott E. Rosenow | Executive, Promoter |
| Leonard P. Ruiz | Director, Executive, Promoter |
| Robert Whalen | Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
421 First Avenue S.W., Suite 304
Rochester, MN, 55902
Rochester, MN, 55902